C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2011
08/09/2011	CA2253240C Hereditary hemochromatosis gene
08/09/2011	CA2146328C C-c ckr-1, c-c chemokine receptor
08/04/2011	WO2011094593A2 Novel lowered affinity antibodies and methods of marking the same
08/04/2011	WO2011094467A2 Methods of treating diabetes with dll4 antagonists
08/04/2011	WO2011094465A1 Methods of treating autoimmune diseases with dll4 antagonists
08/04/2011	WO2011094259A2 Cd127 binding proteins
08/04/2011	WO2011093783A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
08/04/2011	WO2011093426A1 Novel fed-batch culture method
08/04/2011	WO2011093217A1 ANTI-Pandemic (H1N1) 2009 ANTIBODY AND IMMUNOASSAY METHOD USING SAME
08/04/2011	WO2011093097A1 Anti-dll3 antibody
08/04/2011	WO2011092700A1 Antibodies that inhibit metalloproteins
08/04/2011	WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
08/04/2011	WO2011092359A1 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs)
08/04/2011	WO2011092313A1 Rodent combinatorial antibody libraries
08/04/2011	WO2011092294A1 Extracellular ifi16 as therapeutic agents
08/04/2011	WO2011091716A1 Epidermal growth factor receptor variant
08/04/2011	WO2011064395A3 Inhibitors and antagonists of calcium channels in the treatment of asthma
08/04/2011	WO2011057099A3 Treating basal-like genotype cancers
08/04/2011	WO2011034605A3 Coiled coil and/or tether containing protein complexes and uses thereof
08/04/2011	WO2011022725A3 Mimotopes of hiv and uses thereof
08/04/2011	US20110191912 Promoter, promoter control elements, and combinations, and uses thereof
08/04/2011	US20110191875 Compositions and methods for making androstenediones
08/04/2011	US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained
08/04/2011	US20110191866 Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (f-peat) technology
08/04/2011	US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto
08/04/2011	US20110190479 Differential targeting of triacylglycerol synthase and wax synthase activity of the triacylglycerol synthase gene for tuberculosis treatment
08/04/2011	US20110190477 Humanized Anti-C5aR Antibodies
08/04/2011	US20110190445 Inhibition of hrp-3 using modified oligonucleotides
08/04/2011	US20110190223 Hemcm42 nucleic acids
08/04/2011	US20110190154 Methods and compositions for determining the purity of chemically synthesized nucleic acids
08/04/2011	US20110190149 Neoepitope detection of disease using protein arrays
08/04/2011	US20110190144 Novel compositions and methods for the treatment of psoriasis
08/04/2011	US20110189794 Immunoassay with extended detection window
08/04/2011	US20110189711 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
08/04/2011	US20110189696 Monoclonal antibody stro-4
08/04/2011	US20110189694 Methods for detection and diagnosis of a bone or cartilage disorder
08/04/2011	US20110189693 Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148
08/04/2011	US20110189690 Antibody complex, method for detecting antigen, and method for producing anitbody complex
08/04/2011	US20110189688 Genes
08/04/2011	US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus
08/04/2011	US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine
08/04/2011	US20110189203 Immunoglobulin constructs
08/04/2011	US20110189202 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
08/04/2011	US20110189201 Modulation of bone development
08/04/2011	US20110189198 Compositions and Methods for Diagnosing and Treating an Inflammation
08/04/2011	US20110189197 Antibodies Against Protective Antigen
08/04/2011	US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
08/04/2011	US20110189195 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase
08/04/2011	US20110189190 Anti-hepcidin-25 selective antibodies and uses thereof
08/04/2011	US20110189188 Novel gp96 derived peptides
08/04/2011	US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/04/2011	US20110189183 Antibodies against candida, collections thereof and methods of use
08/04/2011	US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases
08/04/2011	US20110189179 Identification of Tumor-Associated Antigens for Diagnosis and Therapy
08/04/2011	US20110189177 Antibodies to vla-1
08/04/2011	US20110189171 Recombinant antibodies for treatment of respiratory syncytial virus infections
08/04/2011	US20110189170 Chimeric Anti-VEGF-D Antibodies and Humanized Anti-VEGF-D Antibodies and Methods of Using the Same
08/04/2011	US20110189168 Antibody-induced apoptosis
08/04/2011	US20110189164 Peptide Stabilizer Compounds and Screening Method
08/04/2011	US20110189158 Clostridial neurotoxins with altered persistency
08/04/2011	US20110189154 Applications For A New Class Of Enzymes: Sulfiredoxins
08/04/2011	US20110189123 Mammalian cx3c chemokine antibodies
08/04/2011	US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
08/04/2011	US20110189101 Fluorescent labeling agent and fluorescent labeling method
08/04/2011	US20110189095 Crkl targeting peptides
08/04/2011	US20110189093 Prostate specific membrane antigen antibodies and antigen binding fragments
08/04/2011	US20110189088 Radiopharmaceutical complexes
08/04/2011	US20110189087 TMPRSS4-Specific Human Antibody
08/04/2011	US20110189085 Antibody Therapy
08/04/2011	US20110189082 Human gm-csf antigen binding proteins
08/04/2011	CA2825282A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
08/04/2011	CA2787615A1 Methods of treating diabetes with dll4 antagonists
08/04/2011	CA2787394A1 Methods of treating autoimmune diseases with dll4 antagonists
08/04/2011	CA2787311A1 Antibodies that inhibit metalloproteins
08/04/2011	CA2787070A1 Cd127 binding proteins
08/04/2011	CA2786817A1 Extracellular ifi16 as therapeutic agents
08/03/2011	EP2351840A1 Polypeptides involved in immune response
08/03/2011	EP2351838A1 Crosslinking agonistic antibodies
08/03/2011	EP2351833A1 Peptide-containing culture medium for culturing animal cell
08/03/2011	EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
08/03/2011	EP2351777A1 Anti-muc1 antibody
08/03/2011	EP2351774A1 Polypeptides from non-typeable haemophilus influenzae
08/03/2011	EP2351773A1 Polypeptides from non-typeable haemophilus influenzae
08/03/2011	EP2351770A1 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
08/03/2011	EP2351584A1 Novel anti-IL 13 antibodies and uses thereof
08/03/2011	EP2351583A1 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
08/03/2011	EP2351483A1 Prevention and treatment of blood coagulation-related diseases
08/03/2011	EP2350663A2 Identification of signature genes associated with hepatocellular carcinoma
08/03/2011	EP2350649A1 Stable antibody compositions and methods for stabilizing same
08/03/2011	EP2350305A1 Combination treatments comprising protease binding proteins for inflammatory disorders
08/03/2011	EP2350304A2 Toll-like receptor 3 antagonists
08/03/2011	EP2350282A1 Increased expression of specific antigens
08/03/2011	EP2350270A2 Human ebola virus species and compositions and methods thereof
08/03/2011	EP2350131A2 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
08/03/2011	EP2350130A1 Purification of acidic proteins using ceramic hydroxyapatite chromatography
08/03/2011	EP2350128A2 Methods for producing antibodies from plasma cells
08/03/2011	EP2350127A1 Isolation and purification of antibodies using protein a affinity chromatography
08/03/2011	EP2350126A1 Bispecific egfr/igfir binding molecules
08/03/2011	EP2350113A1 Aqueous two phase extraction augmented precipitation process for purification of therapeutic proteins
08/03/2011	EP2349335A1 Levetiracetam immunoassays

1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1494